Back to Search
Start Over
Low Omicron BA.4 and BA.5 neutralising activity and breakthrough COVID-19 following pre-exposure prophylaxis with tixagevimab plus cilgavimab in vaccinated patients with autoimmune disease.
- Source :
-
Clinical and experimental rheumatology [Clin Exp Rheumatol] 2023 May; Vol. 41 (5), pp. 1202-1203. Date of Electronic Publication: 2023 Feb 23. - Publication Year :
- 2023
Details
- Language :
- English
- ISSN :
- 0392-856X
- Volume :
- 41
- Issue :
- 5
- Database :
- MEDLINE
- Journal :
- Clinical and experimental rheumatology
- Publication Type :
- Editorial & Opinion
- Accession number :
- 36826787
- Full Text :
- https://doi.org/10.55563/clinexprheumatol/pfli7o